CORONAVIRUS, Health, Science

FDA issues full approval for Pfizer’s COVID-19 vaccine

File photo: Chas Hundley

The U.S. Food and Drug Administration (FDA) today announced full approval of the Pfizer-BioNTech COVID-19 vaccine, which now will be marketed as Comirnaty, for the prevention of the coronavirus in individuals 16 years old or older.

The clinical results of the trial showed the vaccine is 91 percent effective in preventing COVID-19.

The Pfizer-BioNTech vaccine has been available for emergency use authorization in individuals 12 years old or older as of May 10. An FDA press release said official approval of the vaccine means the known and potential benefits of it outweigh “the known and potential risks of the product . . .

You have reached content available exclusively to Banks Post digital subscribers.

We rely on subscribers to keep the lights on in our independent newsroom. Join us with a digital subscription today.

Click here to subscribe.

Receive a 3-day free trial of unlimited digital access.

Already a subscriber? Login here.

Newsletter

The Miller Team
John L Scott Market Center